BATON ROUGE – Critics around the country are asking why Dsuvia is needed. It's a new opioid and a painkiller that has recently received an FDA approval mark but many do not agree and think it's a terrible mistake.
"We are in the middle of the worst epidemic in the country, an opiate epidemic that is likely to kill and hurt more people than any other epidemic than the country or the world has seen," said Coroner Beau Clark.
East Baton Rouge Parish Coroner, Dr. Beau Clark first saw the fatal effects of opioid use with at least 72 overdose deaths in the parish itself this year.
"It looks like a really spectacular ignorance of human life, a substance, opiates that kill people, why we need more when we have a problem with what we have," Clark said.
According to the FDA, there are strict guidelines for a drug that dissolves in the mouth. It can only be used in hospitals, surgical centers and emergency facilities. Dsuvia should not be used for more than 72 hours and is not available in retail pharmacies.
They say it is a drug that will only be administered in a very short space of time in a health care facility in a very controlled environment. That's great if it is. However, later in the statement, they say it was also developed with the Department of Defense, so it is also in contradiction with themselves.
Dr. Scott Gottlieb, in his statement from the FDA, says, "This opioid formulation, along with the unique Dsuvia device, was a medium priority product for the Pentagon, because it complements the specific and critical, but limited, inadequate need to treat our nation's battlefield soldiers, but Dr. Clark does not buy it.
"A soldier is outdoors who protects our country, and if he gets hurt on the battlefield, we must have mechanisms to deal with his pain, especially if he has a long transport time from where he gets injured and ultimate care, but I think these things already exist, "Clark said.
The serious risks of taking Dsuvia include respiratory depression, coma, and even death, not to mention high addiction quality.
"Having stronger and stronger opiates is really a bad direction, and it's definitely sending out the wrong message." In the statement Dr. Gottlieba of Dsuvii added, "We will not avoid what, in my opinion, is the real source of dissatisfaction among the critics of this consent, the question of whether America needs another powerful opioid or not, a massive crisis of addiction."
Gottlieb says that this question will be addressed openly and directly. Dsuvia will round 1.1 billion dollars in annual sales, but Clark is more interested in lives that might be lost in the future.
"We are on our way to another record year of increasing opiates compared to last year, and I do not see the end in sight, and if we do that, we will create another category of even stronger opioids, I think that is causing more and more problems," Clark said.
More information about Dsuvia can be found here.